Flowerkist Skin Care & Cosmetics, Inc. Announces Name Change to Lynx Capital and New Trading Symbol: LYXX

New York, New York – Flowerkist Skin Care & Cosmetics, Inc. is pleased to announce that, effective next week, the Company will officially change its name to Lynx Capital.

As part of this transition, the Company’s common stock will begin trading under the new ticker symbol LYXX. The Company’s existing CUSIP number will remain unchanged.

Key details regarding the corporate action are as follows:

Current Company Name: Flowerkist Skin Care & Cosmetics, Inc.

New Company Name: Lynx Capital

Current Trading Symbol: FKST

New Trading Symbol: LYXX

CUSIP Number: 34350F101 (unchanged)

FINRA Daily List Announcement Date: April 20, 2026

Market Effective Date: April 21, 2026

Management believes the transition to Lynx Capital better reflects the Company’s long-term vision, business strategy, and future direction. The new name aligns with the Company’s broader focus on capital markets, strategic investments, entertainment financing, digital assets, and other growth initiatives.

Shareholders are not required to take any action in connection with the name and ticker symbol change. Existing shareholdings will automatically reflect the new company name and ticker symbol once the change becomes effective in the market.

The Company appreciates the continued support of its shareholders and looks forward to this next chapter as Lynx Capital.

About Lynx Capital

Lynx Capital is focused on strategic investments across a range of sectors, including capital markets, entertainment, digital assets, and other high-growth opportunities. The Company seeks to identify and capitalize on unique transactions that can create long-term value for shareholders.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements due to various factors, including market conditions, regulatory approvals, financing conditions, and other risks beyond the Company’s control.